Cel
The incredible potential of cell and immune therapy (CIT) is limited by technical challenges related to the standard analysis of immune cells in bulk, which neglects their heterogeneity. Single-cell functional resolution is essential to understand the full potential of immune cells. Current single-cell technologies are limited, low-throughput, high-cost and lack robustness, prohibitive for their implementation in CIT R&D, manufacturing and patient stratification. Samplix is developing Xplore, an all-in-one multiparameter single-cell analyser and sorter for screening, selection and expansion of immune cells based on functionality and potency. Xplore is a cost-effective solution that delivers higher throughput and sensitivity than current solutions, being compatible with CIT research workflows. Unlocking the full potential of CIT supports the faster and efficient development of new personalized therapies to treat serious diseases such as cancer, autoimmune diseases, and viral infections.
Dziedzina nauki
Słowa kluczowe
Program(-y)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Zaproszenie do składania wniosków
HORIZON-EIC-2023-ACCELERATOR-01
Zobacz inne projekty w ramach tego zaproszeniaSystem finansowania
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended FinanceKoordynator
3460 Birkerod
Dania
Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.